MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....An alternative approach may be used if such approach satisfies the requirements of the.....conduct and/or complete prescribed studies on production batches of a drug after approval..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
PTC in Manufacture and Testing of Monoclonal Antibody Products for Human Use
...These trials cannot be used by themselves to support licensure of a product.Studies conducted in normal volunteers are not included in.....entity or is produced by a novel process, and when drug development plans are unusually.....generic or modular virus clearance studies are used for multiple antibodies that differ only in the..
http://www.fda.gov/cber/gdlns/ptc_mab.pdf (score=95)
Guidance for Industry
...However, if a radioactive drug is used for immediate therapeutic, diagnostic, or similar purpose.....In studies that compare the effects of a test agent with another drug, biological product.....possible, the formulation that will be used for marketing should be used during phase 2..
http://www.fda.gov/cder/guidance/5742prt3.pdf (score=95)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....Results from photostability studies, when..warranted, should be provided in S.7.3 and..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=92)
Guidance for Industry: Human Somatic Cell Therapy and Gene Therapy
...abbreviate testing and IND submission for a product or product series, the sponsor should.....Virus or DNA preparations used as preventive vaccines are not covered by this document.....Murphy, HFM-17, Center for Biologics Evaluation and Research, Food and Drug Administration..
http://www.fda.gov/cber/gdlns/somgene.pdf (score=91)
...This may be particularly helpful when data from generic or modular virus clearance studies are used.....Sponsors should study a number of separate product lots during drug development to demonstrate that a safe and.....Such clearance studies for product contaminants may have to be repeated when manufacturing schemes are..
http://www.fda.gov/cber/gdlns/ptc_mab.txt (score=91)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....Results from photostability studies, when..warranted, should be provided in S.7.3 and..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=88)
ICH: Guidance on Viral Safety Eveluation of Biotechnology Products Derived...
...and for the removal of virus from product, acceptable level of safety in the final product.....used in the context of the understanding of the biology of the virus and the nature of the.....Food and Drug Administration, AGENCY: Food and Drug Administration, Clearance Officer..
http://www.fda.gov/cber/gdlns/virsafe.pdf (score=83)
...To ensure that a botanical drug product used in clinical trials is of consistently good quality, and.....For initial clinical studies on a botanical drug product that is not currently lawfully.....The clinical data generated from these studies conducted without an IND can be used to support an NDA if the studies..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=79)
Pediatric Rule
...In the development of a new drug or biological product, decisions about appropriate populations to study and.....that are dangerous to health when used in the manner prescribed, recommended, or suggested.....this age group with caution and would, whenever appropriate, permit such studies to occur..
http://www.fda.gov/cder/guidance/pedrule.pdf (score=78)
stability guidance -draft
...Information to support the stability of the drug product during the toxicologic studies and the.....and the test methods used to monitor the stability of the drug product packaged in the.....These studies are used to identify precautionary measures needed in manufacturing or..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=76)
Safety and Effectiveness of New Drugs & Biological Products in Pediatric...
...Where there is evidence that a drug product is widely used in pediatric patients, failure to provide adequate.....Although the preamble to the 1994 rule recognizes FDA's authority to require drug manufacturers to conduct pediatric studies on a.....The type of formulation needed would vary depending on the age group in which the product were to be used and..
http://www.fda.gov/cder/guidance/pedrule.htm (score=74)
Guidance for Industry: Developing Medical Imaging Drug and Biological...
...demonstrating whether the proposed drug product is safe for use under the conditions prescribed.....However, if a radioactive drug is used for immediate therapeutic, diagnostic, or similar purposes.....biologically active in animal studies or in human studies when administered at dosages..
http://www.fda.gov/cber/gdlns/medimagesaf.pdf (score=71)
6003dft.doc
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....to assist in the design and conduct of studies used to collect the technical information.....therefore, real-time concurrent stability studies on the product potentially affected by..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=3)
Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....This guideline is intended to assist in the design and conduct of studies used to collect the.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=3)
International Conference on Harmonisation; Draft Guidance on Q5E...
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....to assist in the design and conduct of studies used to collect the technical information.....therefore, real-time concurrent stability studies on the product potentially affected by..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=3)
Prescription Drug Promotion FAQs
...call attention to the name of the drug product but do not include indications or dosage.....The phrase "drug of choice," or any similar phrase or presentation, used in an.....labeling which calls attention to the name of the drug product but does not include indications..
http://www.fda.gov/cder/ddmac/FAQS.HTM (score=1)
...3 Specifications The tests and analytical procedures chosen to define drug substance or drug product.....This guideline is intended to assist in the design and conduct of studies used to collect the.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cder/guidance/6003dft.doc (score=1)
Guidance For the Submission of Documentation for Sterilization Process
...other processes should be addressed as each applies to the drug product,sterile packaging and.....The sensitivity of the experimental method used for container-closure integrity testing.....demonstrate the effects of loading on thermal input to product. Additional studies may be necessary if..
http://www.fda.gov/cber/gdlns/sterval.pdf (score=0)
Document
...methods that optimize safety, safety and effectiveness of the product, studies contemplated under.....to convene a panel of pediatric experts, existing drug advisory committees, FDA agrees.....used sparingly in all age groups, group. in which FDA should permit deferral, including..
http://www.fda.gov/ohrms/dockets/98fr/120298c.pdf (score=0)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
